Skip to main content

Want a detailed portfolio tracker?

Entero Therapeutics, Inc. Common Stock (ENTO) Debt to Equity (2024 - 2025)

Entero Therapeutics, Inc. Common Stock (ENTO) debt to equity from Jun 30, 2024 to Sep 30, 2025. The current Entero Therapeutics, Inc. Common Stock (ENTO) debt to equity is 2.51%. You can export chart.

Debt to Equity

Annual Debt to Equity change of Entero Therapeutics, Inc. Common Stock (ENTO)

YearDebt to EquityChange
20252.51%N/A
20240.00%N/A

Comparison Entero Therapeutics, Inc. Common Stock (ENTO) debt to equity with competitors

Entero Therapeutics, Inc. Common Stock (ENTO) debt to equity is 2.51%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-98.94%
ARVNArvinas Inc0.13%-94.85%
GHRSGH Research PLC0.16%-93.47%
ATHEAlterity Therapeutics Ltd0.18%-92.77%
CGONCg Oncology Inc0.27%-89.06%
PHVSPharvaris NV0.31%-87.55%
OSRHBellevue Life Sciences Acquisition Corp0.37%-85.31%
GLPGGalapagos NV0.37%-85.11%
VTVTvTv Therapeutics Inc - Class A0.46%-81.68%
BDRXBiodexa Pharmaceuticals Plc0.53%-78.70%
LPTXLeap Therapeutics Inc0.68%-72.92%
CMNDClearmind Medicine Inc0.74%-70.33%
CBUSCibus Global Ltd. Class A0.75%-70.03%
ABVCABVC BioPharma Inc0.82%-67.19%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-65.22%
PPCBPropanc Biopharma Inc1.05%-58.08%
ARGXArgen X SE1.14%-54.59%
OCSOculis Holding AG1.14%-54.47%
XRTXXORTX Therapeutics Inc1.17%-53.29%
IMMPImmutep Ltd1.22%-51.29%
CANFCan-Fite Biopharma Ltd1.27%-49.43%
RVPHReviva Pharmaceuticals Holdings Inc1.33%-47.18%
BNTXBioNTech SE1.62%-35.50%
NBPNovaBridge Biosciences.1.74%-30.53%
NRXSNeuraxis Inc1.75%-30.19%
IMABI-Mab1.77%-29.50%
IFRXInflaRx N.V.2.23%-11.14%
ONCOOnconetix Inc2.47%-1.70%
GANXGain Therapeutics Inc2.67%+6.22%
NCNANuCana plc3.04%+21.09%
ADXNAddex Therapeutics Ltd3.11%+23.93%
SXTP60 Degrees Pharmaceuticals Inc3.29%+30.97%
IMTXImmatics N.V3.31%+31.78%
YMABY-Mabs Therapeutics Inc3.66%+45.77%
IRONDisc Medicine Inc4.27%+69.89%
LGVNLongeveron Inc - Class A4.67%+85.88%
MOLNMolecular Partners AG4.89%+94.57%
NCELNLS Pharmaceutics Ltd4.90%+95.02%
ADAGAdagene Inc5.23%+108.39%
PRTCPureTech Health plc American Depositary Shares5.56%+121.60%
ALXOAlx Oncology Holdings Inc5.62%+124.00%
REGNRegeneron Pharmaceuticals Inc6.32%+151.75%
ANROAlto Neuroscience Inc6.58%+162.19%
MDXGMimedx Group Inc7.24%+188.45%
GDTCCytoMed Therapeutics Ltd7.37%+193.68%
MRNAModerna Inc7.96%+217.21%
QLGNQualigen Therapeutics, Inc. Common Stock8.40%+234.56%
BEAMBeam Therapeutics Inc8.60%+242.70%
PBYIPuma Biotechnology Inc8.79%+249.95%
PYPDPolypid Ltd9.00%+258.61%
KURAKura Oncology Inc9.04%+259.92%
SLNOSoleno Therapeutics Inc10.06%+300.62%
VRAXVirax Biolabs Group Ltd - Class A10.13%+303.38%
SVASinovac Biotech Ltd11.15%+344.01%
RIGLRigel Pharmaceuticals11.25%+348.19%
MAZEMaze Therapeutics Inc11.36%+352.64%
ABEOAbeona Therapeutics Inc12.48%+397.02%
CLDICalidi Biotherapeutics Inc12.62%+402.80%
ACIUAC Immune SA13.65%+443.61%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%+482.37%
VERAVera Therapeutics Inc - Class A15.01%+498.02%
ALTAltimmune Inc15.25%+507.23%
NUVBNuvation Bio Inc - Class A16.62%+562.02%
SVRASavara Inc17.08%+580.26%
ACHVAchieve Life Sciences Inc17.21%+585.59%
DYNDyne Therapeutics Inc17.27%+587.75%
HRMYHarmony Biosciences Holdings Inc17.45%+594.83%
SPRBSpruce Biosciences Inc18.66%+643.05%
RCUSArcus Biosciences Inc19.08%+660.09%
INVAInnoviva Inc19.24%+666.18%
MDWDMediWound Ltd19.62%+681.32%
TARSTarsus Pharmaceuticals Inc20.80%+728.61%
XNCRXencor Inc21.05%+738.34%
TCRXTscan Therapeutics Inc22.51%+796.40%
APLSApellis Pharmaceuticals Inc22.59%+799.85%
CNTACentessa Pharmaceuticals plc22.66%+802.57%
BMRNBiomarin Pharmaceutical Inc23.02%+817.02%
TSHATaysha Gene Therapies Inc23.10%+820.08%
FBIOFortress Biotech Inc23.12%+820.78%
MESOMesoblast Ltd23.52%+836.62%
HYFTMindWalk Holdings Corp23.71%+844.52%
ONCBeiGene Ltd24.13%+861.24%
LXRXLexicon Pharmaceuticals Inc24.49%+875.49%
NKTRNektar Therapeutics24.89%+891.41%
ICCCImmucell Corp29.87%+1089.63%
CRSPCRISPR Therapeutics AG32.27%+1185.08%
ZLABZai Lab Ltd32.30%+1186.46%
QUREuniQure N.V.33.44%+1231.91%
ABOSAcumen Pharmaceuticals Inc35.49%+1313.60%
ALDXAldeyra Therapeutics Inc36.29%+1345.50%
PRQRProQR Therapeutics N.V36.40%+1349.90%
OBIOOrchestra BioMed Holdings Inc36.41%+1350.35%
COGTCogent Biosciences Inc36.72%+1362.69%
ELABPMGC Holdings Inc37.62%+1398.29%
ASBPAspire Biopharma Holdings Inc38.75%+1443.55%
MLTXMoonLake Immunotherapeutics - Class A38.98%+1452.51%
LEGNLegend Biotech Corp40.23%+1502.28%
PHXMPHAXIAM Therapeutics SA ADR42.62%+1597.67%
PHARPharming Group N.V.43.21%+1620.81%
XFORX4 Pharmaceuticals Inc44.52%+1673.31%
REPLReplimune Group Inc50.14%+1896.89%
ADMAAdma Biologics Inc50.44%+1908.80%
CLGNCollPlant Biotechnologies Ltd New54.22%+2059.35%
BLRXBioline Rx Ltd54.40%+2066.65%
SRPTSarepta Therapeutics Inc55.69%+2117.98%
ARQTArcutis Biotherapeutics Inc57.70%+2197.96%
MDGLMadrigal Pharmaceuticals Inc62.62%+2394.21%
CAICaris Life Sciences Inc - Class A64.29%+2460.71%
SRRKScholar Rock Holding Corp71.23%+2737.13%
INSMInsmed Inc76.93%+2963.86%
ATAIATAI Life Sciences N.V.83.95%+3243.72%
VRNAVerona Pharma Plc87.12%+3369.87%
IONSIonis Pharmaceuticals Inc88.01%+3405.37%
RYTMRhythm Pharmaceuticals Inc88.25%+3415.02%
RPRXRoyalty Pharma plc - Class A90.13%+3489.90%
CDXSCodexis Inc93.64%+3629.43%
ALECAlector Inc94.08%+3646.92%
GMABGenmab94.17%+3650.84%
TTRXTurn Therapeutics Inc97.04%+3764.99%
GERNGeron Corp109.92%+4278.02%
XOMAXOMA Royalty Corp110.48%+4300.46%
TLXTelix Pharmaceuticals Ltd112.45%+4378.87%
HCWBHCW Biologics Inc114.14%+4446.00%
JAZZJazz Pharmaceuticals plc118.15%+4605.56%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%+4651.67%
TGTXTG Therapeutics Inc127.78%+4989.40%
ARDXArdelyx Inc136.94%+5353.96%
FOLDAmicus Therapeutics Inc143.18%+5602.68%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%+5721.85%
AAPGAscentage Pharma Group International149.47%+5853.31%
SLXNSilexion Therapeutics Corp149.83%+5867.44%
OPTOpthea Ltd156.18%+6120.43%
SPRYARS Pharmaceuticals Inc157.44%+6170.52%
NMRANeumora Therapeutics Inc159.82%+6265.53%
MISTMilestone Pharmaceuticals Inc161.42%+6329.32%
CLLSCellectis181.25%+7118.86%
ASNDAscendis Pharma A/S183.75%+7218.61%
FTREFortrea Holdings Inc200.32%+7878.59%
AIMAIM ImmunoTech Inc.215.25%+8472.98%
CELCCelcuity Inc257.58%+10159.21%
HOWLWerewolf Therapeutics Inc262.95%+10372.87%
VALNValneva SE273.15%+10779.26%
ALLRAllarity Therapeutics Inc290.17%+11457.19%
HUMAHumacyte Inc308.59%+12190.87%
AXSMAxsome Therapeutics Inc344.13%+13606.19%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%+16786.52%
PGENPrecigen Inc462.16%+18307.35%
OCGNOcugen Inc502.91%+19930.24%
SNDXSyndax Pharmaceuticals Inc840.90%+33391.90%
HALOHalozyme Therapeutics Inc976.45%+38790.67%
EDITEditas Medicine Inc1240.40%+49303.51%
RVNCRevance Therapeutics Inc1477.84%+58760.26%
IOBTIO Biotech Inc1829.20%+72754.37%